Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Exits RNAi, Raising Questions For Stalwarts

Dec 01 2010

Related Content

Merck Nabs Pole Position in RNAi With $1.1 Billion Sirna Buy

Nov 01 2006

Alnylam Takes Platform Monetization to a Whole New and Non-Exclusive Level

Jul 01 2007

Related Companies

Alnylam Pharmaceuticals Inc.

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

Novartis AG

Roche Holding AG

Arbutus Biopharma Corporation

Merck & Co., Inc.

Sirna Therapeutics

Pfizer Inc.

Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd.

Dicerna Pharmaceuticals, Inc.

Additional Topics

BioPharmaceutical

More from In Vivo Archive

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window